Brief: Adaptive Biotechnologies Q3 EPS USD 0.02
04/11/2026 21:06
BRIEF-Adaptive Biotechnologies Q3 EPS USD 0.02 Nov 04 (Reuters) - Adaptive Biotechnologies Q3 net income USD 2.806 million.
- Q3 revenue USD 83.902 million vs. IBES estimate USD 71.6 million
- Q3 operating expenses USD 84.359 million
- Q3 operating income USD -457 thousand
- Q3 adjusted EBITDA USD 14.3 million vs. IBES estimate USD -495 thousand
Recent news on Adaptive Biotechnologies
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Adaptive Biotechnologies Corporation reports results for the quarter ended September 30 - Earnings Summary
Adaptive Biotechnologies Q3 revenue falls 11% but beats estimates
Brief: Adaptive Biotechnologies Q3 EPS USD 0.02
Advisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn